Role of IL-33 and its receptor in T cell-mediated autoimmune diseases

38Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Interleukin-33 (IL-33) is a new cytokine of interleukin-1 family, whose specific receptor is ST2. IL-33 exerts its functions via its target cells and plays different roles in diseases. ST2 deletion and exclusion of IL-33/ST2 axis are accompanied by enhanced susceptibility to dominantly T cell-mediated organ-specific autoimmune diseases. It has been reported that IL-33/ST2 pathway plays a key role in host defense and immune regulation in inflammatory and infectious diseases. This review focuses on new findings in the roles of IL-33 and ST2 in several kinds of T cell-mediated autoimmune diseases. © 2014 Qing Zhao and Guangjie Chen.

Cite

CITATION STYLE

APA

Zhao, Q., & Chen, G. (2014). Role of IL-33 and its receptor in T cell-mediated autoimmune diseases. BioMed Research International. Hindawi Publishing Corporation. https://doi.org/10.1155/2014/587376

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free